Nada B.

Nada B. serves as a Medical Advisor at Mallinckrodt Pharmaceuticals, focusing on cell therapy and immunology, with responsibilities in onco-hematology, solid organ transplantation, and onco-dermatology across France and Iberia since September 2023. Prior experience includes roles as a Medical Science Liaison at Medical Developments International from October 2022 to June 2023, a Junior Medical Advisor at Ipsen from May 2022 to September 2022, and a Research Assistant at Novartis Institutes for BioMedical Research in 2020-2021. Nada holds a Doctor of Pharmacy degree from medical school, a Master 2 in Biotechnology and Cell Engineering from Universite de Lorraine, and LTK-1 certification from the University of Zurich's Institute of Laboratory Animal Science.